Skip to main content
. 2020 Aug 13;11(3):419–467. doi: 10.1007/s13167-020-00215-0

Table 7.

A total of 10 hub molecules in invasive NFPAs identified with PPI analysis of 130 overlapped molecules (invasive DEG; phosphoproteins)

Protein accession ID DEG name DEG level Protein name Phosphorylation level
logFC AveExpr t P value Phosphopeptide Phosphorylated site Phosphorylated position Phosphorylated probabilities PEP Score Ratio (T/N) P value (t test)
Q8WXD2 SCG3 1.2843 10.4326 4.3052 1.72E-03 Secretogranin-3 ELS*AERPLNEQIAEAEEDKIK S 37 1 2.80E-38 149 0.46 1.50E-04
LFPAPS*EKSHEETDSTK S 359 0.468 1.85E-02 36
P49815 TSC2 2.1795 10.7866 6.3857 9.73E-05 Tuberin S*SSSPELQTLQDILGDPGDK S; S; S 1385; 1386; 1387 0.313; 0.313; 0.313 1.56E-11 74
P02768-1 ALB 1.9536 6.1289 4.5055 1.27E-03 Serum albumin TCVADES*AENCDK S 82 1 1.24E-47 197 0.74 3.24E-04
P31749 AKT1 1.1801 6.8509 5.4900 3.11E-04 RAC-alpha serine/threonine-protein kinase S*GSPSDNSGAEEMEVSLAKPK S; S 122; 124 0.457; 0.457 1.16E-07 92
A5PL32 APOL1 − 1.1936 9.8189 − 3.2480 9.26E-03 Apolipoprotein L1 VTEPIS*AES*GEQVER S; S 352; 355 1; 1 2.53E-03 59 0.71 5.33E-03
Q13085 ACACA 1.1822 6.8754 3.3664 7.62E-03 Acetyl-CoA carboxylase 1 FIIGSVSEDNS*EDEISNLVK S 29 1 3.35E-32 154 2.98 6.08E-05
Q14515 SPARCL1 − 3.1871 13.6134 − 4.7627 8.66E-04 SPARC-like protein 1 EES*HEQS*AEQGK S 80 9.37E-38 176 0.24 1.86E-05
SSS*QELGLK S 92 0.999 1.61E-28 188 0.28 1.91E-05
SKEES*HEQS*AEQGK S; S 80; 84 0.999; 1 9.37E-38 176 0.35 5.38E-05
EHANS*KQEEDNTQSDDILEESDQPTQVSK S 231 1 5.61E-70 176 0.36 5.25E-04
HIQETEWQS*QEGK S 295 1 2.83E-21 152 0.57 1.15E-03
DQGNQEQDPNIS*NGEEEEEKEPGEVGTHNDNQER S 198 0.997 1.10E-05 53 0.89 1.92E-01
EHANS*KQEEDNT*QS*DDILEESDQPTQVSK S; T; S 231; 238; 240 0.331; 0.331; 0.331 1.44E-02 38
S*KEES*HEQSAEQGK S; S 76; 80 0.999; 0.995 7.77E-05 77
P14672 SLC2A4 − 1.3065 5.1362 − 4.4148 1.45E-03 Solute carrier family 2, facilitated glucose transporter member 4 T*PSLLEQEVKPSTELEYLGPDEND T; S 486; 488 0.5; 0.5 1.85E-10 91
P05060 CHGB − 1.3288 14.5253 − 3.2997 8.51E-03 Secretogranin-1 SETHAAGHS*QEK S 225 1 4.87E-30 175 0.14 6.87E-07
GRGS*EEYR S 367 1 1.70E-07 146 0.12 7.46E-07
AS*EEEPEYGEEIK S 335 1 5.81E-71 223 0.13 2.05E-06
EKSS*QES*GEETGS*QENHPQESK S; S; S 236; 239; 245 0.531; 1; 0.965 4.20E-73 205 0.06 3.67E-06
ADEPQWSLYPSDS*QVS*EEVK S; S 146; 149 0.999; 0.999 1.30E-150 236 0.31 5.28E-06
SSQESGEET*GSQENHPQESK T 243 0.978 1.47E-45 161 0.02 5.36E-06
GERGEDS*S*EEK S; S 182; 183 1; 1 1.80E-03 100 0.16 7.03E-06
AS*EEEPEY*GEEIK S; Y 335; 341 1; 1 2.35E-06 98 0.18 8.29E-06
SSQES*GEETGS*QENHPQESK S; S 239; 245 0.992; 1 4.20E-73 205 0.06 1.01E-05
S*QREDEEEEEGENYQK S 160 1 1.77E-17 140 0.25 1.17E-05
SAEFPDFYDS*EEPVSTHQEAENEKDR S 626 1 1.85E-99 214 0.26 1.18E-05
S*QEES*EEGEEDATS*EVDK S 259; 263; 272 1; 1; 0.857 1.51E-53 157 0.14 1.23E-05
SSQGGS*LPSEEK S 298 0.981 3.28E-14 142 0.28 1.31E-05
DPADASEAHES*SSR S 98 0.966 1.32E-30 169 0.10 1.41E-05
NYPS*LELDK S 391 1 1.30E-04 112 0.14 1.44E-05
ADEPQWSLYPS*DS*QVSEEVK S; S 144; 146 0.941; 0.751 3.58E-98 136 0.52 1.53E-05
EKSS*QES*GEET*GSQENHPQESK S; S; T 237; 239; 243 0.819; 0.935; 0.598 1.47E-45 161 0.05 1.53E-05
SSQGGSLPS*EEK S 301 0.999 5.51E-20 128 0.25 1.88E-05
S*AEFPDFYDSEEPVSTHQEAENEKDR S 617 1 8.30E-152 246 0.22 2.13E-05
S*AEFPDFY*DSEEPVSTHQEAENEKDR Y 624 0.995 8.86E-43 152 0.23 2.23E-05
SQEESEEGEEDAT*SEVDK T 271 0.973 1.38E-88 219 0.21 2.23E-05
M#AHGY*GEES*EEER Y; S 401; 405 1; 1 2.41E-02 51 0.23 2.34E-05
ERADEPQWSLYPSDSQVS*EEVK S 149 1 2.83E-147 264 0.29 2.80E-05
PQS*EES*WDEEDKR S; S 377; 380 1; 1 4.73E-42 181 0.15 3.27E-05
SAEFPDFYDS*EEPVS*THQEAENEK S; S 626; 631 0.996; 0.863 3.45E-35 140 0.30 3.33E-05
SS*QGGSLPSEEK S 294 0.807 3.74E-09 133 0.24 3.77E-05
S*SQGGSLPSEEK S 293 0.992 1.97E-30 180 0.25 4.48E-05
GHPQEES*EESNVSMASLGEK S 311 1 6.58E-209 232 0.22 5.91E-05
SAEFPDFYDSEEPVS*T*HQEAENEK S; T 631; 632 0.591; 0.586 3.45E-35 124 0.31 5.94E-05
EKS*S*QES*GEET*GS*QENHPQESK S; S; S; T; S 235; 236; 239; 243; 245 0.643; 0.589; 0.589; 0.589; 0.589 1.47E-45 161 0.05 7.50E-05
WQQQGDLQDT*KENR T 492 1 6.83E-05 85 0.37 9.99E-05
GHPQEES*EESNVS*M#ASLGEK S 317 0.988 1.45E-59 184 0.29 1.70E-04
ADEPQWSLY*PSDSQVS*EEVK Y; S 142; 149 0.981; 0.96 6.42E-108 134 0.52 1.87E-04
GHPQEES*EESNVS*MAS*LGEK S; S; S 314; 320; 323 0.739; 1; 1 1.83E-50 161 0.37 4.40E-04
WAEGGGHS*R S 130 1 4.86E-03 80 0.21 5.96E-04
GHPQEES*EES*NVS*MASLGEK S; S; S 314; 317; 320 0.959; 0.959; 0.959 8.63E-27 145 0.31 6.63E-04
CIIEVLSNALS*K S 46 1 3.06E-04 94 0.40 1.63E-02
DHHS*THYRASEEEPEY*GEEIK S; T; Y 329; 330; 341 0.355; 0.355; 0.98 1.56E-02 43
DPADASEAHESS*S*RGEAGAPGEEDIQGPTK S; S 99; 100 0.651; 0.651 8.57E-07 62
LLRDPADAS*EAHESSSR S 93 0.989 5.88E-05 88
S*ETHAAGHS*QEK S 217 0.757 1.02E-02 78
P24593 IGFBP5 − 2.6828 10.6639 − 4.1430 2.20E-03 Insulin-like growth factor-binding protein 5 EHEEPT*TSEMAEETYSPK T 123 0.346 2.19E-04 56

DEG, differentially expressed gene; LogFC, log2(fold change). LogFC > = 1, upregulated DEG; LogFC <= − 1, downregulated DEGs; Ratio (T/N), the ratio of phosphorylation level of NFPAs to controls